The development of bladder cancer stimulated by the laminin/integrin α6β4/TRB3/JAG1/Notch pathway could be inhibited by Notch inhibitor SAHM1, which described a new strategy in the treatment of bladder cancer. This evidence concerns the gene LAMB2 and urinary bladder carcinoma.